COST MINIMIZATION ANALYSIS OF EMICIZUMAB IN THE PROPHYLAXIS OF INHIBITOR-NEGATIVE PATIENTS WITH HEMOPHILIA A IN TURKEY

Guler, B.Oksuz, E.Malhan, S.Yanik, L.Koc, E.2020-10-012020-10-0120191098-3015http://hdl.handle.net/11727/4813enginfo:eu-repo/semantics/closedAccessCOST MINIMIZATION ANALYSIS OF EMICIZUMAB IN THE PROPHYLAXIS OF INHIBITOR-NEGATIVE PATIENTS WITH HEMOPHILIA A IN TURKEYConference Object22S851S851000503167003155